Skip to main content
OpenTrials

Clinical trial condition

Genetic Diseases, Inborn

Explore clinical trials studying Genetic Diseases, Inborn. Study availability and eligibility vary by location and protocol.

12,656 public trials 2,147 recruiting studies
Refine in advanced search Browse all conditions

Genetic Diseases, Inborn trial results

Completed

Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSC

NCT05495425

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +13 more
Locations
  • Fujita Health University Hospital Toyoake, Aichi-ken, Japan
  • Gunma University Hospital Maebashi, Gunma, Japan
  • Osaka University Hospital Suita, Osaka, Japan
  • Seirei Hamamatsu General Hospital Hamamatsu, Shizuoka, Japan
View Trial Details
Completed

Salt Supplementation in Gitelman Syndrome

NCT04995627

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +7 more
Locations
  • University Hospital of University of Campania "L. Vanvitelli" Naples, Italy
  • Radboudumc Nijmegen, Gelderland, Netherlands
  • Erasmus MC Rotterdam, South Holland, Netherlands
View Trial Details
Completed

Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan

NCT02808403

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Hypercholesterolemia, +10 more
Locations
  • Research Site Ichinomiya, Aichi-ken, Japan
  • Research Site Ichinomiya, Aichi-ken, Japan
  • Research Site Inuyama, Aichi-ken, Japan
  • Research Site Kasugai, Aichi-ken, Japan
View all 138 locations
View Trial Details
Completed

Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Microsatellite Stable (MSS) Colorectal Cancer (CRC) (MK-7690-046)

NCT03631407

Conditions
Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +19 more
Locations
  • Honor Health ( Site 0103) Scottsdale, Arizona, United States
  • California Cancer Associates for Research & Excellence ( Site 0100) Encinitas, California, United States
  • California Cancer Associates for Research & Excellence ( Site 0102) Fresno, California, United States
  • Florida Cancer Specialists (South Region) - Research Office ( Site 7001) Fort Myers, Florida, United States
View Trial Details
Completed

Ablation in Brugada Syndrome for the Prevention of VF

NCT02704416

Conditions
Arrhythmias, Cardiac, Brugada Syndrome, Cardiac Conduction System Disease, +7 more
Locations
  • Academic Medical Center, University of Amsterdam Amsterdam, Netherlands
  • Bhumipol Adulyadej Hospital, Royal Thai Air Force Bangkok, Thailand
  • Chulalongkorn University Bangkok, Thailand
  • Pacific Rim Electrophysiology Research Institute Data Coordinating Center Bangkok, Thailand
View Trial Details
Completed

Safety and Efficacy of Pembrolizumab (MK-3475) Plus Binimetinib Alone or Pembrolizumab Plus Chemotherapy With or Without Binimetinib in Metastatic Colorectal Cancer (mCRC) Participants (MK-3475-651/KEYNOTE-651)

NCT03374254

Conditions
Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +20 more
Locations
  • City of Hope National Medical Center ( Site 0102) Duarte, California, United States
  • Anschutz Medical Campus, Anschutz Cancer Pavilion ( Site 0106) Aurora, Colorado, United States
  • Yale Cancer Center ( Site 0108) New Haven, Connecticut, United States
  • Moffitt Cancer Center ( Site 0111) Tampa, Florida, United States
View all 14 locations
View Trial Details
Completed

Implementation and Evaluation of a Rare Disease Algorithm to Identify Persons at Risk of Gaucher Disease Using Data From Electronic Health Records (EHRs) in the United States (Project Searchlight)

NCT05908656

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
Locations
  • University of Florida 655 W 8th St- Site Number : 8400003 Gainesville, Florida, United States
  • Metropolitan Hospital Center- Site Number : 8400001 New York, United States
  • Aurora Research Institute LLC- Site Number : 8400002 Milwaukee, Wisconsin, United States
View Trial Details

Related conditions